Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
March-April 2011 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-April 2011 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis

  • Authors:
    • Tsukasa Kitahashi
    • Mitsuyoshi Yoshimoto
    • Toshio Imai
  • View Affiliations / Copyright

    Affiliations: Central Animal Laboratory, National Cancer Center Research Institute, Tokyo 104-0045, Japan, Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Tokyo 104-0045, Japan
  • Pages: 229-234
    |
    Published online on: January 21, 2011
       https://doi.org/10.3892/ol.2011.252
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic ductal carcinomas and early ductal lesions in Syrian hamsters have been reported to show histopathological resemblance to those in humans. Specific protein expression profiles have been found in human carcinomas, but a detailed molecular approach regarding the dissection of BOP-induced pancreatic carcinogenesis has yet to be determined. The present immunohistochemical study of early and advanced hamster lesions focused on five proteins reported to be overexpressed in human patients, to clarify interspecies phenotype similarity. Integrin αVβ3 was found to be overexpressed in the epithelial cells of 13 of 14 atypical hyperplasias and 6 of 6 adenocarcinomas. This overexpression was more frequent than in the remaining four proteins. However, immunoreactivity for α-enolase in epithelial cells and for kallikrein 7 and galectin-1/3 in both epithelial and stromal cells was also evident at various frequencies. Thus, similarities of tumor-associated protein expression between human and hamster pancreatic ductal lesions were confirmed, and integrin αVβ3 was identified as a potentially useful immuno- histochemical marker for early lesions in hamsters.
View Figures
View References

1 

Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W and Sobue T; the Japanese Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol. 38:641–648. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Michaud DS: Epidemiology of pancreatic cancer. Minerva Chir. 59:99–111. 2004.PubMed/NCBI

3 

Tsukuma H, Ajiki W, Ioka A and Oshima A: Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 36:602–607. 2006. View Article : Google Scholar : PubMed/NCBI

4 

De Braud F, Cascinu S and Gatta G: Cancer of pancreas. Crit Rev Oncol Hematol. 50:147–155. 2004.PubMed/NCBI

5 

Hosotani R, Kawaguchi M, Masui T, Koshiba T, Ida J, Fujimoto K, Wada M, Doi R and Imamura M: Expression of integrin αVβ3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas. 25:e30–e35. 2002.

6 

Johnson SK, Ramani VC, Hennings L and Haun RS: Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer. 109:1811–1820. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Shen J, Person MD, Zhu J, Abbruzzese JL and Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 64:9018–9026. 2004. View Article : Google Scholar

8 

Shimamura T, Sakamoto M, Ino Y, Shimada K, Kosuge T, Sato Y, Tanaka K, Sekihara H and Hirohashi S: Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin Cancer Res. 8:2570–2575. 2002.PubMed/NCBI

9 

Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM and Goldenberg DM: New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol. 24:252–258. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y and Yamao K: Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol. 45:52–59. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Rivera JA, Graeme-Cook F, Werner J, Z’graggen K, Rustgi AK, Rattner DW, Warshaw AL and Fernández-del Castillo C: A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens. Surgery. 122:82–90. 1997. View Article : Google Scholar : PubMed/NCBI

12 

Osvaldt AB, Wendt LR, Bersch VP, de Cássia A, Schumacher R, Edelweiss MI and Rohde L: Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. Surgery. 140:803–809. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Pour P, Althoff J, Kruger FW and Mohr U: A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst. 58:1449–1453. 1977.PubMed/NCBI

14 

Hingorani SR, Petricoin EF, Maitra A, et al: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4:437–450. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T and Tsuda H: Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis. 27:2497–2510. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Fujii H, Egami H, Chaney W, Pour P and Pelling J: Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog. 3:296–301. 1990.PubMed/NCBI

17 

Li J, Weghorst CM, Tsutsumi M, Poi MJ, Knobloch TJ, Casto BC, Melvin WS, Tsai MD and Muscarella P: Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. Carcinogenesis. 25:263–268. 2004.

18 

Tsujiuchi T, Sasaki Y, Kubozoe T, Konishi Y and Tsutsumi M: Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters. Mol Carcinog. 36:60–66. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M and Kamano T: Early ductal lesions of pancreatic carcinogenesis in animals and humans. Int J Pancreatol. 7:83–89. 1990.PubMed/NCBI

20 

Roda O, Chiva C, Espuna G, Gabius H, Real FX, Navarro P and Andreu D: A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics. 6:S36–S41. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Carreiras F, Lehmann M, Sichel F, Marvaldi J, Gauduchon P and Le Talaer JY: Implication of the αVβ3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int J Cancer. 63:530–536. 1995.

22 

Yokosaki Y, Monis H, Chen J and Sheppard D: Differential effects of the integrins α9β1, αVβ3, and αVβ6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J Biol Chem. 271:24144–24150. 1996.

23 

Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nährig J, Watzlowik P, Wester HJ, Harbeck N and Schwaiger M: Patterns of αVβ3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med. 49:255–259. 2008.

24 

Hansson L, Strömqvist M, Bäckman A, Wallbrandt P, Carlstein A and Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem. 269:19420–19426. 1994.PubMed/NCBI

25 

Barondes SH, Castronovo V, Cooper DN, et al: Galectins: a family of animal β-galactoside-binding lectins. Cell. 76:597–598. 1994.

26 

Perillo NL, Marcus ME and Baum LG: Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med. 76:402–412. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Maeda N, Kawada N, Seki S, Ikeda K, Iwao H, Okuyama H, Hirabayashi J, Kasai K and Yoshizato K: Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem. 278:18938–18944. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Zhou W, Capello M, Fredolini C, Piemonti L, Liotta LA, Novelli F and Petricoin EF: Mass spectrometry analysis of the post-translational modifications of α-enolase from pancreatic ductal adenocarcinoma cells. J Proteome Res. 9:2929–2936. 2010.

29 

Ahmed M and Bergsten P: Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry. Diabetologia. 48:477–485. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kitahashi T, Yoshimoto M and Imai T: Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis. Oncol Lett 2: 229-234, 2011.
APA
Kitahashi, T., Yoshimoto, M., & Imai, T. (2011). Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis. Oncology Letters, 2, 229-234. https://doi.org/10.3892/ol.2011.252
MLA
Kitahashi, T., Yoshimoto, M., Imai, T."Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis". Oncology Letters 2.2 (2011): 229-234.
Chicago
Kitahashi, T., Yoshimoto, M., Imai, T."Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis". Oncology Letters 2, no. 2 (2011): 229-234. https://doi.org/10.3892/ol.2011.252
Copy and paste a formatted citation
x
Spandidos Publications style
Kitahashi T, Yoshimoto M and Imai T: Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis. Oncol Lett 2: 229-234, 2011.
APA
Kitahashi, T., Yoshimoto, M., & Imai, T. (2011). Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis. Oncology Letters, 2, 229-234. https://doi.org/10.3892/ol.2011.252
MLA
Kitahashi, T., Yoshimoto, M., Imai, T."Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis". Oncology Letters 2.2 (2011): 229-234.
Chicago
Kitahashi, T., Yoshimoto, M., Imai, T."Novel immunohistochemical marker, integrin αVβ3, for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis". Oncology Letters 2, no. 2 (2011): 229-234. https://doi.org/10.3892/ol.2011.252
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team